Novel inactivation of the causative fungal pathogen of white-nose syndrome with methoxsalen plus ultraviolet A or B radiation

White-nose syndrome is a fungal disease responsible for the rapid decline of North American bat populations. This study addressed a novel method for inactivating Pseudogymnoascus destructans, the causative agent of WNS, using ultraviolet A (UVA) or B (UVB) radiation in combination with methoxsalen,...

Full description

Bibliographic Details
Main Authors: Colin J. Hartman, Joseph C. Mester, Patrick M. Hare, Alan I. Cohen, Louise A. Rollins-Smith
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485863/?tool=EBI
_version_ 1818554495860211712
author Colin J. Hartman
Joseph C. Mester
Patrick M. Hare
Alan I. Cohen
Louise A. Rollins-Smith
author_facet Colin J. Hartman
Joseph C. Mester
Patrick M. Hare
Alan I. Cohen
Louise A. Rollins-Smith
author_sort Colin J. Hartman
collection DOAJ
description White-nose syndrome is a fungal disease responsible for the rapid decline of North American bat populations. This study addressed a novel method for inactivating Pseudogymnoascus destructans, the causative agent of WNS, using ultraviolet A (UVA) or B (UVB) radiation in combination with methoxsalen, a photosensitizer from the furanocoumarin family of compounds. Fungal spore suspensions were diluted in micromolar concentrations of methoxsalen (50–500 μM), then exposed to fixed doses of UVA radiation (500–5000 mJ/cm2), followed by plating on germination media. These plates were examined for two to four weeks for evidence of spore germination or inactivation, along with resultant growth or inhibition of P. destructans colonies. Pretreatment of fungal spores with low doses of methoxsalen resulted in a UVA dose-dependent inactivation of the P. destructans spores. All doses of methoxsalen paired with 500 mJ/cm2 of UVA led to an approximate two-log10 (~99%) reduction in spore viability, and when paired with 1000 mJ/cm2, a four-log10 or greater (>99.99%) reduction in spore viability was observed. Additionally, actively growing P. destructans colonies treated directly with methoxsalen and either UVA or UVB radiation demonstrated UV dose-dependent inhibition and termination of colony growth. This novel approach of using a photosensitizer in combination with UV radiation to control fungal growth may have broad, practical application in the future.
first_indexed 2024-12-12T09:40:26Z
format Article
id doaj.art-544b8fafc00c4d14ad646444f9675e6c
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-12T09:40:26Z
publishDate 2020-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-544b8fafc00c4d14ad646444f9675e6c2022-12-22T00:28:34ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01159Novel inactivation of the causative fungal pathogen of white-nose syndrome with methoxsalen plus ultraviolet A or B radiationColin J. HartmanJoseph C. MesterPatrick M. HareAlan I. CohenLouise A. Rollins-SmithWhite-nose syndrome is a fungal disease responsible for the rapid decline of North American bat populations. This study addressed a novel method for inactivating Pseudogymnoascus destructans, the causative agent of WNS, using ultraviolet A (UVA) or B (UVB) radiation in combination with methoxsalen, a photosensitizer from the furanocoumarin family of compounds. Fungal spore suspensions were diluted in micromolar concentrations of methoxsalen (50–500 μM), then exposed to fixed doses of UVA radiation (500–5000 mJ/cm2), followed by plating on germination media. These plates were examined for two to four weeks for evidence of spore germination or inactivation, along with resultant growth or inhibition of P. destructans colonies. Pretreatment of fungal spores with low doses of methoxsalen resulted in a UVA dose-dependent inactivation of the P. destructans spores. All doses of methoxsalen paired with 500 mJ/cm2 of UVA led to an approximate two-log10 (~99%) reduction in spore viability, and when paired with 1000 mJ/cm2, a four-log10 or greater (>99.99%) reduction in spore viability was observed. Additionally, actively growing P. destructans colonies treated directly with methoxsalen and either UVA or UVB radiation demonstrated UV dose-dependent inhibition and termination of colony growth. This novel approach of using a photosensitizer in combination with UV radiation to control fungal growth may have broad, practical application in the future.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485863/?tool=EBI
spellingShingle Colin J. Hartman
Joseph C. Mester
Patrick M. Hare
Alan I. Cohen
Louise A. Rollins-Smith
Novel inactivation of the causative fungal pathogen of white-nose syndrome with methoxsalen plus ultraviolet A or B radiation
PLoS ONE
title Novel inactivation of the causative fungal pathogen of white-nose syndrome with methoxsalen plus ultraviolet A or B radiation
title_full Novel inactivation of the causative fungal pathogen of white-nose syndrome with methoxsalen plus ultraviolet A or B radiation
title_fullStr Novel inactivation of the causative fungal pathogen of white-nose syndrome with methoxsalen plus ultraviolet A or B radiation
title_full_unstemmed Novel inactivation of the causative fungal pathogen of white-nose syndrome with methoxsalen plus ultraviolet A or B radiation
title_short Novel inactivation of the causative fungal pathogen of white-nose syndrome with methoxsalen plus ultraviolet A or B radiation
title_sort novel inactivation of the causative fungal pathogen of white nose syndrome with methoxsalen plus ultraviolet a or b radiation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485863/?tool=EBI
work_keys_str_mv AT colinjhartman novelinactivationofthecausativefungalpathogenofwhitenosesyndromewithmethoxsalenplusultravioletaorbradiation
AT josephcmester novelinactivationofthecausativefungalpathogenofwhitenosesyndromewithmethoxsalenplusultravioletaorbradiation
AT patrickmhare novelinactivationofthecausativefungalpathogenofwhitenosesyndromewithmethoxsalenplusultravioletaorbradiation
AT alanicohen novelinactivationofthecausativefungalpathogenofwhitenosesyndromewithmethoxsalenplusultravioletaorbradiation
AT louisearollinssmith novelinactivationofthecausativefungalpathogenofwhitenosesyndromewithmethoxsalenplusultravioletaorbradiation